See other companies on Welcome to the Jungle
Arctoris
Tech-enabled biopharma company
- 21-100 employees
- Healthcare
- B2B
- Enterprise
- Robotics
- Milton, UK
Jump to section
Company mission
To use robotics to provide drug discovery data on demand for researchers in biotech, pharma and academia.
55% employee growth in 12 months
Our take
Founded in 2015, Arctoris has grown from a technology startup to a globally operating company delivering integrated drug discovery projects. It provides drug discovery companies, pharmaceutical corporations and academic centres with fully automated Experiments-as-a-Service powered by robotics. This allows Arctoris to accelerate innovation and speed up the drug discovery process.
The drug discovery ecosystem is evolving rapidly, and the key to success is having access to the right data at the right time, to progress the right projects toward the clinic. Arctoris plays a vital role in enabling true data-driven drug discovery and the company set itself apart being the world’s first fully automated R&D platform dedicated to drug discovery.
Arctoris has partners on three continents from its headquarters in Oxford and its Asia-Pacific hub in Singapore. Arctoris will be focused on developing the proprietary technology behind its robots, expanding its service offering, hiring top talent and building a new laboratory facility.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Learn something new every single day, be challenged, and develop
- Work with stellar colleagues - doctors, engineers, scientists, marketers, and many more
- Life, health and wellbeing support
- You have the opportunity to choose how and where you work
- Personal development fund to continue your own professional journey
- Highly competitive compensation packages
Company values
- Collaboration
- Authencity
- Innovation
- Excellence
Funding (last 2 of 7 rounds)
Feb 2021
$0.6m
GRANT
Oct 2020
$3.7m
SEED
Total funding: $10.2m
This company has top investors
Leadership
A clinician-scientist, Martin is a Rhodes scholar, an active member of several European cancer research organisations, and a member of the Young Academy of the German National Academy of Sciences.
Tom Fleming
(COO)Previously SME Leader at Royal Academy of Engineering for 1 year and Visiting Research Scientist at GSK. Tom has an MChem from Oxford where he is a Fellow of the Royal Commission of 1851.